AMPA receptor potentiators: application for depression and Parkinson's disease.
about
Sigma receptors: potential targets for a new class of antidepressant drugPiracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptorsTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesMolecular Mechanism of Flop Selectivity and Subsite Recognition for an AMPA Receptor Allosteric Modulator: Structures of GluA2 and GluA3 in Complexes with PEPAGlutamate receptor ion channels: structure, regulation, and functionNon-Pharmacological Treatments for ADHD in YouthFrom synapse to nucleus: novel targets for treating depression.Evidence of altered polyamine concentrations in cerebral cortex of suicide completersChallenges for and current status of research into positive modulators of AMPA receptors.New targets for rapid antidepressant action.Drugs and their molecular targets: an updated overview.Adiponectin protects rat hippocampal neurons against excitotoxicity.Role of conformational dynamics in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism.Novel Glutamatergic Treatments for Severe Mood Disorders.The free energy landscapes governing conformational changes in a glutamate receptor ligand-binding domainMaximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.The role of AMPA receptor modulation in the treatment of neuropsychiatric diseasesIonotropic glutamate receptors & CNS disorders.Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderNeurotransmission in Parkinson's disease: beyond dopamine.The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.AMPA receptor positive allosteric modulators: a patent review.Anthocyanins protect against kainic acid-induced excitotoxicity and apoptosis via ROS-activated AMPK pathway in hippocampal neurons.Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.Transmembrane AMPA receptor regulatory proteins and cornichon-2 allosterically regulate AMPA receptor antagonists and potentiatorsMulti-level control of ionotropic glutamate receptor function.Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors
P2860
Q24567770-375DED49-6276-4D9A-979D-7E9F45BD0E5DQ24611731-45D89135-4D7F-4BCB-B73E-0E0E195DE9F4Q27004490-23F42AA9-125B-4B86-B5F2-0ACBE32BF082Q27023257-74941209-6F3C-46CB-A6E0-364F5FA9DBD6Q27660095-DC2AEE4E-5239-4598-831A-32D16D5EF5CAQ28290774-40B55F04-2248-4EB2-B06B-40B6BFBFFA83Q30377445-128F182E-2926-42C4-902C-7188EA6BB8F4Q33653177-54A09FE2-5332-420D-8A72-CAF3F738C22CQ33868443-0E244054-4D94-476A-818A-DB9431364C82Q33870362-1F62A33A-AFA4-40A5-A66E-0A0ED8AAB603Q34507177-6D495BAD-D085-4288-B94E-EC43711687D9Q34746522-B69D1625-B745-4041-BB1F-2EFAB0E09DCEQ35080193-912CC610-F213-48D0-9EA3-E6C4B09A6E60Q36481794-ED49FF7A-E17F-45E8-AC27-AF6FD9D1DD1EQ36498659-915268EA-A7B1-4A3A-BF79-D3508786BDBEQ36528592-A0806296-A615-46C4-87C4-CAD9011309B9Q36648773-903DE666-7A0F-426C-BACC-749FF6F27B9DQ36740187-BF3DB9B1-219E-4025-A2A8-CFFBF0ACFE53Q37143580-D9BB5ED5-89CE-4571-A4F1-9F8076D2F3AAQ37183932-F2068D0D-1FBC-4DE5-8963-EED6161D0AF0Q37668014-3978F7C1-C76D-483B-9ABD-F98DC049AD1EQ37668684-24C1996B-B7DF-4488-AD12-43939D52D99CQ37855933-67B54AA6-17E2-4E88-87C0-67B908220BBBQ38081162-D26ABB33-0C22-40AC-8E2F-CF1CC848AA81Q39037105-412DD31A-1CDA-4C23-8487-E34C6058C852Q39557334-641D8D2F-6739-4BE3-B65B-C636739CB375Q41958491-52EA0BE8-433E-4984-904C-4C40D32F7FF6Q42920059-69A90F86-3C72-45F7-9BDA-AA1739B7D080Q58694067-C0481210-835A-4F4D-8727-10EFF78D63F1
P2860
AMPA receptor potentiators: application for depression and Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
AMPA receptor potentiators: application for depression and Parkinson's disease.
@ast
AMPA receptor potentiators: application for depression and Parkinson's disease.
@en
AMPA receptor potentiators: application for depression and Parkinson's disease.
@nl
type
label
AMPA receptor potentiators: application for depression and Parkinson's disease.
@ast
AMPA receptor potentiators: application for depression and Parkinson's disease.
@en
AMPA receptor potentiators: application for depression and Parkinson's disease.
@nl
prefLabel
AMPA receptor potentiators: application for depression and Parkinson's disease.
@ast
AMPA receptor potentiators: application for depression and Parkinson's disease.
@en
AMPA receptor potentiators: application for depression and Parkinson's disease.
@nl
P1433
P1476
AMPA receptor potentiators: application for depression and Parkinson's disease.
@en
P2093
Jeffrey M Witkin
Michael J O'Neill
P304
P356
10.2174/138945007780618517
P577
2007-05-01T00:00:00Z